Hyperbaric oxygen therapy for chronic wounds
This KCE has read for you was prepared by Nadia Benahmed, Patriek Mistiaen
- Hyperbaric oxygen therapy (HBOT) is the administration of pure oxygen (100%) at pressures greater than atmospheric pressure in a compression chamber. By increasing partial pressure of oxygen to hypoxic wound tissues, HBOT is considered as an adjuvant treatment for chronic ulcers of the lower limb.
- According to a review published in February 2015 by the Cochrane Collaboration, HBOT significantly improved, in diabetic patients with foot ulcers, the ulcer healing in the short term (up to 6 weeks) but not in the long term. HBOT did not allow to reduce the rate of major amputations in this patient group. In venous ulcers, HBOT may reduce the size of wounds. Overall, safety of HBOT could not be
- The conclusions of the Cochrane’s review are in line with a previous KCE report published in 2008 (KCE Reports 74C- 2008).
KCE has read for you synthesises a recently published high-quality systematic review or health technology assessment with relevance for the Belgian health system.
The original publication was appraised and contextualised by KCE researchers. KCE has read for you is not based on original research conducted by KCE.
More details on methodology can be found on the KCE website.
This document includes
- Key findings of the publication under evaluation
- A contextualisation within the Belgian healthcare system
- Detailed descriptions
Trustworthy original publication
The methodological quality of the systematic review was assessed with the AMSTAR tool.